289. Prolonged Corticosteroid Usage, Associated Infectious Complications, and High Mortality in Adult Patients with COVID-19

BACKGROUND: Based on the RECOVERY trial, the NIH strongly recommends systemic corticosteroids for COVID-19 pneumonia with hypoxia. The study demonstrated reduced 28-day mortality after dexamethasone 6mg daily for up to 10 days compared to SOC alone. In practice, physicians may continue therapy for l...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Rebecca, Zafonte, Veronica B, Cervellione, Kelly L, Miele, Andrew S, Bagheri, Farshad, Shakil, Javeria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751755/
http://dx.doi.org/10.1093/ofid/ofac492.367

Ejemplares similares

Ejemplares similares